JPH053476B2 - - Google Patents

Info

Publication number
JPH053476B2
JPH053476B2 JP59225543A JP22554384A JPH053476B2 JP H053476 B2 JPH053476 B2 JP H053476B2 JP 59225543 A JP59225543 A JP 59225543A JP 22554384 A JP22554384 A JP 22554384A JP H053476 B2 JPH053476 B2 JP H053476B2
Authority
JP
Japan
Prior art keywords
oxime
compound
ethyl acetate
acid
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59225543A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61103890A (ja
Inventor
Shigeo Morimoto
Takashi Adachi
Toshibumi Asaga
Yoshiaki Watanabe
Kaoru Soda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16830937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH053476(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP59225543A priority Critical patent/JPS61103890A/ja
Priority to US06/789,771 priority patent/US4680386A/en
Priority to AU48973/85A priority patent/AU574233B2/en
Priority to DE8585307680T priority patent/DE3575729D1/de
Priority to EP85307680A priority patent/EP0180415B1/en
Priority to ZA858212A priority patent/ZA858212B/xx
Priority to DK198504905A priority patent/DK172636B1/da
Publication of JPS61103890A publication Critical patent/JPS61103890A/ja
Publication of JPH053476B2 publication Critical patent/JPH053476B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP59225543A 1984-10-26 1984-10-26 ６−０−メチルエリスロマイシンａ誘導体 Granted JPS61103890A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP59225543A JPS61103890A (ja) 1984-10-26 1984-10-26 ６−０−メチルエリスロマイシンａ誘導体
US06/789,771 US4680386A (en) 1984-10-26 1985-10-21 6-O-methylerythromycin a derivative
AU48973/85A AU574233B2 (en) 1984-10-26 1985-10-23 6-0-methyl erythromycin a derivative
DE8585307680T DE3575729D1 (en) 1984-10-26 1985-10-24 6-o-methylerythromycin a derivative
EP85307680A EP0180415B1 (en) 1984-10-26 1985-10-24 A 6-0-methylerythromycin A derivative
ZA858212A ZA858212B (en) 1984-10-26 1985-10-25 6-o-methylerythromycin a derivative
DK198504905A DK172636B1 (en) 1984-10-26 1985-10-25 6-o-methylerythromycin a derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59225543A JPS61103890A (ja) 1984-10-26 1984-10-26 ６−０−メチルエリスロマイシンａ誘導体

Publications (2)

Publication Number Publication Date
JPS61103890A JPS61103890A (ja) 1986-05-22
JPH053476B2 true JPH053476B2 (en]) 1993-01-14

Family

ID=16830937

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59225543A Granted JPS61103890A (ja) 1984-10-26 1984-10-26 ６−０−メチルエリスロマイシンａ誘導体

Country Status (7)

Country Link
US (1) US4680386A (en])
EP (1) EP0180415B1 (en])
JP (1) JPS61103890A (en])
AU (1) AU574233B2 (en])
DE (1) DE3575729D1 (en])
DK (1) DK172636B1 (en])
ZA (1) ZA858212B (en])

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4833236A (en) * 1986-05-02 1989-05-23 Taisho Pharmaceutical Co., Ltd. Erythromycin derivatives
EP0260938B1 (en) 1986-09-18 1992-12-09 Taisho Pharmaceutical Co. Ltd Erythromycin a derivatives and method for preparing the same
US4921839A (en) * 1987-02-24 1990-05-01 Beecham Group P.L.C. Erythromycin a 11,12-carbonate 9-oxime derivatives
YU45033B (en) * 1987-04-14 1991-06-30 Pliva Zagreb Process for preparing 10,11,12,13-tetrahydro derivative
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
GB8721165D0 (en) * 1987-09-09 1987-10-14 Beecham Group Plc Chemical compounds
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
SI9010556B (sl) * 1990-03-21 1998-10-31 Pliva Oleandomicin oksimi in postopek za njihovo pripravo
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
DE69227713D1 (de) * 1991-03-15 1999-01-14 Merck & Co Inc 9-Deoxo-9(Z)-hydroxyiminoerythromycin A und O-Derivate hiervon
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5858986A (en) 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
DE97934319T1 (de) 1996-07-29 2004-08-26 Abbott Laboratories, Abbott Park Herstellung von kristallinen form ii von clarithromycin
HRP960509A2 (en) * 1996-10-30 1998-06-30 Pliva Pharm & Chem Works Novel polyhydro tylosin derivatives and a process for the preparation thereof
US5945405A (en) 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US5864023A (en) * 1997-02-13 1999-01-26 Abbott Laboratories 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
US5929219A (en) * 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
US5852180A (en) * 1997-11-17 1998-12-22 Abbott Laboratories Chemical synthesis of 6-O-alkyl erythromycin A
IL135792A0 (en) * 1997-12-01 2001-05-20 Abbott Lab 6-o-alkyl derivatives of erythronolide b
US5932710A (en) * 1997-12-01 1999-08-03 Abbott Laboratories Process for preparing 6-O-alkyl-9-oxime erythromycin B
US5892008A (en) * 1997-12-16 1999-04-06 Abbott Laboratories Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
GB9827355D0 (en) 1998-12-11 1999-02-03 Biochemie Sa Organic compounds
CA2292359C (en) 1999-01-28 2004-09-28 Pfizer Products Inc. Novel azalides and methods of making same
SK15162001A3 (sk) * 1999-05-24 2003-02-04 Pfizer Products Inc. Deriváty 13-metylerytromycínu
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
KR20010008496A (ko) * 1999-07-01 2001-02-05 유충식 6-오-메틸 에리트로마이신의 제조방법
KR20020070991A (ko) 1999-12-16 2002-09-11 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 다형체 및 신규의 다형체 ⅳ의 제조 방법
DK1280535T3 (da) 2000-01-11 2005-04-04 Teva Pharma Processer til fremstilling af clarithromycin polymorfer
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
HRP20020709A2 (en) * 2000-02-29 2004-12-31 Teva Pharma Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
US6605707B1 (en) 2000-03-23 2003-08-12 Abbott Laboratories Process for the preparation of 6-O-propargyl erythromycin derivatives
KR20030011797A (ko) * 2000-03-28 2003-02-11 바이오케미 게젤샤프트 엠베하 맛이 차폐된 과립형 입자
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US6843854B2 (en) 2002-05-31 2005-01-18 Purdue Research Foundation Method and apparatus for separating a component from a mixture
JP2006528189A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
EP1653925A1 (en) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2572292A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2009023191A2 (en) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of clarithromycin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS5896097A (ja) * 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンｂ誘導体
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives

Also Published As

Publication number Publication date
EP0180415A3 (en) 1986-10-29
EP0180415B1 (en) 1990-01-31
ZA858212B (en) 1986-07-30
AU574233B2 (en) 1988-06-30
AU4897385A (en) 1986-05-01
DE3575729D1 (en) 1990-03-08
EP0180415A2 (en) 1986-05-07
JPS61103890A (ja) 1986-05-22
DK490585A (en) 1986-04-27
DK172636B1 (en) 1999-03-22
DK490585D0 (en) 1985-10-25
US4680386A (en) 1987-07-14

Similar Documents

Publication Publication Date Title
JPH053476B2 (en])
JP4100955B2 (ja) ４”−置換−９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシンａ誘導体類の製造法
JP3099366B2 (ja) ５−ｏ−デソサミニルエリスロノライド誘導体
JP2001500855A (ja) 抗菌活性を有する６―ｏ―置換ケトリド
KR101051369B1 (ko) 항염증 활성을 가진 매크로라이드 화합물
JPH0676432B2 (ja) エリスロマイシンａ誘導体の選択的メチル化方法
JP2002510701A (ja) １５員ラクタム系からの新規なケトライド
JPS6360032B2 (en])
JP2002530423A (ja) 新規な中間体、それを用いたマイクロライド系抗生物質の製造方法
US4833236A (en) Erythromycin derivatives
JPS6360031B2 (en])
JP2782793B2 (ja) エリスロマイシンａ誘導体およびその製造方法
EP0503932A1 (en) 9-Deoxo-9(z)-hydroxy-iminoerythromycin A and O-derivatives thereof
EP0081305B1 (en) Erythromycin a derivatives
JP2001515844A (ja) ３−デスクラジノース６−ｏ−置換エリスロマイシン誘導体
JP2013537213A (ja) クラジノース環のＣ−４”をエポキシド基で修飾した９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシンＡの新規製造方法
US5602239A (en) 5-O-desosaminylerythronolide derivatives
JP2008515968A (ja) ２’−デオキシ−２’，２’−ジフルオロシチジンの製造方法
EP0508725A1 (en) Novel process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
JPS6152839B2 (en])
EP0490311B1 (en) Derivatives of 10,11,12,13-tetra-hydrodesmycosin, processes for preparation, and use thereof in obtaining pharmaceuticals
KR850001961B1 (ko) 3"-아실화 매크롤라이드 항생물질의 제조방법
JPH0529038B2 (en])
WO2004007518A1 (en) Erythromycin a 9-o-pseudosaccharinyloxime derivatives and process for the preparation of clarithromycin using the same
JPH06247996A (ja) ６−ｏ−メチルエリスロマイシンａ誘導体

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term